Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. - Wikidata - awgldk - TriplyDB

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

http://www.wikidata.org/entity/Q33905597

about

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes Ten years of Nature Reviews Neuroscience: insights from the highly cited Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study Towards molecular imaging of multiple sclerosis.Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.Functional neuroimaging in geriatric depression.Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment. Involvement of cell cycle activation Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.Mixed-affinity binding in humans with 18-kDa translocator protein ligands.Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging study Current imaging strategies in rheumatoid arthritis Decreased microglial activation in MS patients treated with glatiramer acetate.TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.Influence of TSPO genotype on 11C-PBR28 standardized uptake values.Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713.Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation.Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.A molecular imaging primer: modalities, imaging agents, and applications.Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.In vivo PET imaging of neuroinflammation in Alzheimer's disease.In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells.Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.Anatomy assisted PET image reconstruction incorporating multi-resolution joint entropy.Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo.Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum.Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.Sifting through the surfeit of neuroinflammation tracers.Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.

P2860

Q28078621-BF3B17C7-9162-4AD6-8329-2E38E3256E72 Q28386297-A3C6F72A-C7B1-4429-8DA3-2FD15CCA9DE1 Q28392661-90B76D2E-2A51-4413-B92B-741B645A80D6 Q33787779-0F404A7A-1DE3-458E-8606-6604FAEA7A3B Q33834306-2EF55175-F3B1-4128-9D18-243BEA3486E9 Q33887659-106621A2-B999-4755-B8C1-D9C172B27366 Q34028561-6F287021-BC05-41D7-AF99-FE068D04A3F4 Q34341513-7338423F-636F-4A20-9726-8D4D8D682F1B Q34408079-E4DBC15C-B776-4608-9748-B1EF608CC69C Q35181349-C483E1FF-3380-4232-87DE-AED67B0E0737 Q35743178-D58E5084-7C62-4E1B-B980-1ED3328B967B Q36070781-B85FB265-D16F-4D45-9C64-C7CBC10393B9 Q36337258-97F24A88-03F7-43E3-A726-16FC35AEC036 Q36338408-EB0CADE8-B00C-40D0-9D65-5B6EF6586556 Q36396082-A77C8CBB-678C-4E99-8353-2430DC0AEB34 Q36915357-63E76839-E6F9-4C47-8CCD-6843A8D111AE Q37087243-2A32E908-3E28-45C8-BF40-661E15470F54 Q37332188-A87EDDDD-8C98-4F84-96A1-78B3E5C0BA0B Q37392949-83B143EC-1046-4D84-8391-AA54BA63B5CC Q37526428-A9672BD1-124E-4609-B1AD-A4E946713172 Q37584734-689DFD23-99CA-4730-82D9-E047A92F5BA5 Q37634177-E7A34562-6609-4E19-A84E-FFAC6611D999 Q37718960-262D6D43-8EEA-4F98-A46F-461FCAB6C6BE Q38005672-E72F5DA7-810E-444D-AABF-F6A898846212 Q38018550-790C3724-950C-41F5-B12C-9887E0E0A17A Q38244707-DBA555D4-88EA-4C22-97DF-2F42FEAA3F48 Q38667698-C1E5E1E3-6314-4C92-AAA9-601176BC6B5C Q38779574-5577687A-16C1-41FD-8CE0-303FF2EBBB6B Q39415063-0C62AB83-7F50-4314-984E-7D3A07424C53 Q39459275-93DE15F7-9E85-40B1-A557-E371ADD278D8 Q39666235-3D5E313A-0D96-4BDC-9F5B-1336B3DD5148 Q40369760-869ABC83-FBFD-465B-B80C-1465532259D2 Q41475934-CE3C4BF5-3BBA-4D9A-93BF-FB2D8977D991 Q41823077-93174D45-9546-4B9E-A08E-FB9773684C4F Q41964688-7025929B-597E-4A37-B434-3908C8CAF8A5 Q44837532-45BB820F-E1A6-49A5-AD3F-A985B3D4F1C9 Q45401909-ED048CAC-DBF5-47DC-AA35-A92BD41B4AFC Q46087990-BC0F68DD-13BF-4302-A693-FB8B05DE2F3D Q47277552-47950BD2-8BE9-450B-898F-C2A0FFDBAD07 Q47291761-A92A3D14-E934-4309-BC9A-09BE5ED01196

P2860

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

http://www.wikidata.org/entity/Q33905597

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@ast

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@en

type

label

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@ast

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@en

prefLabel

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@ast

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@en

P1433

Q33905597-29FCCC10-E41A-44D0-8899-33ECD712E6DF

P1476

Q33905597-8281E089-D6B6-48D1-8CE8-9228549ACB45

P2093

Q33905597-1D30959E-2F9B-4807-B9A4-2836054BF81E

Q33905597-1D6F8E99-2DA0-4DAD-9463-F35E59DF8CC1

Q33905597-42A38EF4-84E4-4802-BEA4-08CE67D00D95

Q33905597-8279E4FF-60B3-40CB-8A87-F8F70C3FFDD2

Q33905597-8A0B35CD-7BF9-4201-9ED4-48CED54C5A6F

Q33905597-926BB999-2ADB-4A66-B917-5382A3E2FAA8

Q33905597-996D7F30-5259-419D-990B-70F8656BCDC2

Q33905597-B6B1EA93-008C-4FC0-A1A8-C9FF812111C8

Q33905597-BB47DB56-B72F-46CA-8852-1F49F60F265D

Q33905597-E2696888-390C-4F0A-A4A7-44F079FF3376

P2860

Q33905597-1695AE71-609D-4821-9B31-8B2765C57CE7

Q33905597-1859EE3E-BDEA-41E2-8889-64F49A9EB8DF

Q33905597-1FCEA386-6F1D-4C4C-A20F-4B5AAEDD2EAA

Q33905597-20B5C337-1A23-4DB2-9748-AF1BB1A56ED8

Q33905597-2281C95A-F615-4FB7-9AB5-29BB932F5862

Q33905597-24F5151D-C8AD-471C-B0F7-65C71CE83DB2

Q33905597-45D3A811-428E-43BF-AA93-C0098D8C6D9F

Q33905597-4CDC435A-C4BE-4C64-88DB-67B60E3E82AE

Q33905597-536AC5B0-4466-4C60-ACDB-AE62A962A5BB

Q33905597-55353156-865C-4E83-ACEE-8DF6BBDE2CCF

P304

Q33905597-1872FE86-28AE-44FF-93C5-6671EE768E6D

P31

Q33905597-0C9FF996-3780-4BC2-92F0-3B89C4F2318B

P356

Q33905597-760A5371-224A-4D91-B291-1F3064DEBFBA

P407

Q33905597-924E162E-772E-4B53-83F2-6E6493DBD3F9

P433

Q33905597-E9ED87E0-B189-4306-B6EB-37B59E652E6F

P478

Q33905597-F80E9373-D5E4-4E21-8BBD-87C88A575ADF

P577

Q33905597-14AA5492-9CF9-41EC-97E8-D2B555733F2E

P5875

Q33905597-4A981BFA-BC12-43C7-81A8-90C1EB7BED60

P698

Q33905597-AEEADC14-4341-4379-A15E-80B48D580604

P932

Q33905597-42E6B2CE-61C7-49ED-B4DC-F536278EA6BB

P356

JNUMED.109.062265

P1433

The Journal of Nuclear Medicine

P1476

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

@en

P2093

Aaron Reynolds

http://www.w3.org/2001/XMLSchema#string

Christopher J Endres

http://www.w3.org/2001/XMLSchema#string

Crystal C Watkins

http://www.w3.org/2001/XMLSchema#string

Dima A Hammoud

http://www.w3.org/2001/XMLSchema#string

John Hilton

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Michael Kassiou

http://www.w3.org/2001/XMLSchema#string

Michelle James

http://www.w3.org/2001/XMLSchema#string

Ovsev Uzuner

http://www.w3.org/2001/XMLSchema#string

Robert F Dannals

http://www.w3.org/2001/XMLSchema#string

P2860

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain

Microglia: a sensor for pathological events in the CNS

Like cops on the beat: the active role of resting microglia.

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands.

P304

1276-1282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.109.062265

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26681092

http://www.w3.org/2001/XMLSchema#string

P698

19617321

http://www.w3.org/2001/XMLSchema#string

P932

2883612

http://www.w3.org/2001/XMLSchema#string